FR2357246A1 - Nouvelles compositions therapeutiques douees d'activite anti-inflammatoire, antalgique et anti-cellulitique - Google Patents
Nouvelles compositions therapeutiques douees d'activite anti-inflammatoire, antalgique et anti-cellulitiqueInfo
- Publication number
- FR2357246A1 FR2357246A1 FR7621141A FR7621141A FR2357246A1 FR 2357246 A1 FR2357246 A1 FR 2357246A1 FR 7621141 A FR7621141 A FR 7621141A FR 7621141 A FR7621141 A FR 7621141A FR 2357246 A1 FR2357246 A1 FR 2357246A1
- Authority
- FR
- France
- Prior art keywords
- hydrolase
- compsns
- adrenalin
- thyroxine
- contg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01001—Alpha-amylase (3.2.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21001—Chymotrypsin (3.4.21.1)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compositions thérapeutiques administrables par la voie externe. Ces compositions sont caractérisées en ce qu'elles comprennent une hydrolase, de la thyroxine et de l'adrenaline, associées à un excipient cutanéo-pénétrant ainsi qu'éventuellement à de l'acétatolamide et/ou à de l'héparine et/ou à des vitamines ou à des facteurs vitaminiques. Application au traitement externe de troubles inflammatoires, d'algies et de la cellulite.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7621141A FR2357246A1 (fr) | 1976-07-09 | 1976-07-09 | Nouvelles compositions therapeutiques douees d'activite anti-inflammatoire, antalgique et anti-cellulitique |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7621141A FR2357246A1 (fr) | 1976-07-09 | 1976-07-09 | Nouvelles compositions therapeutiques douees d'activite anti-inflammatoire, antalgique et anti-cellulitique |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2357246A1 true FR2357246A1 (fr) | 1978-02-03 |
FR2357246B1 FR2357246B1 (fr) | 1978-12-22 |
Family
ID=9175539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7621141A Granted FR2357246A1 (fr) | 1976-07-09 | 1976-07-09 | Nouvelles compositions therapeutiques douees d'activite anti-inflammatoire, antalgique et anti-cellulitique |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2357246A1 (fr) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989007454A1 (fr) * | 1988-02-11 | 1989-08-24 | Ulf Per Gustav Smith | Preparation pharmaceutique de traitement des obstructions des poumons |
WO1990015600A2 (fr) * | 1989-06-19 | 1990-12-27 | A.H. Robins Company, Incorporated | Traitement pour maladie chronique inflammatoire des articulationspar des arylsulfonamides |
WO1996040048A2 (fr) * | 1995-06-07 | 1996-12-19 | Karo Bio Ab | Utilisations innovantes d'hormones thyroidiennes ou de composes ressemblant a des hormones thyroidiennes |
WO2001019391A1 (fr) * | 1999-09-14 | 2001-03-22 | New Horizons Diagnostics, Inc. | Traitement topique d'infections streptococciques |
US6380255B1 (en) | 1995-06-07 | 2002-04-30 | Karo Bio Ab | Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
US6685937B2 (en) | 1997-10-31 | 2004-02-03 | New Horizons Diagnostics Corp. | Chewing gum containing phage associated lytic enzymes for treating streptococcal A infections |
US6733749B2 (en) | 1997-10-31 | 2004-05-11 | New Horizons Diagnostics Corporation | Throat lozenges for the treatment of Hemosphilus influenza |
US6737079B2 (en) | 1997-10-31 | 2004-05-18 | New Horizons Diagnostics Corporation | Bandage composition containing a phage associated lytic enzyme |
US6752988B1 (en) | 2000-04-28 | 2004-06-22 | New Horizons Diagnostic Corp | Method of treating upper resiratory illnesses |
EP1438968A1 (fr) * | 2003-01-16 | 2004-07-21 | L'oreal | Compositions pour application topique comprenant au moins un polypeptide de la famille des hydrolases à activité amidasique et/ou un produit capable de moduler son activité |
US6875431B2 (en) | 1997-10-31 | 2005-04-05 | New Horizons Diagnostics Corp. | Method for the treatment of bacterial eye infections |
US6893635B2 (en) | 1997-10-31 | 2005-05-17 | New Horizons Diagnostics Corp | Therapeutic treatment of upper respiratory infections using a nasal spray |
US7063837B2 (en) | 1999-09-14 | 2006-06-20 | New Horizons Diagnostics Corp | Syrup composition containing phage associated lytic enzymes |
US7232576B2 (en) | 1997-10-31 | 2007-06-19 | New Horizons Diagnostics Corp | Throat lozenge for the treatment of Streptococcus Group A |
US7687069B2 (en) | 1997-10-31 | 2010-03-30 | Vincent Fischetti | Time release patch containing phage associated lytic enzymes for treating bacterial infections of the skin |
-
1976
- 1976-07-09 FR FR7621141A patent/FR2357246A1/fr active Granted
Non-Patent Citations (1)
Title |
---|
NEANT * |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989007454A1 (fr) * | 1988-02-11 | 1989-08-24 | Ulf Per Gustav Smith | Preparation pharmaceutique de traitement des obstructions des poumons |
WO1990015600A2 (fr) * | 1989-06-19 | 1990-12-27 | A.H. Robins Company, Incorporated | Traitement pour maladie chronique inflammatoire des articulationspar des arylsulfonamides |
WO1990015600A3 (fr) * | 1989-06-19 | 1992-08-06 | Robins Co Inc A H | Traitement pour maladie chronique inflammatoire des articulationspar des arylsulfonamides |
EP1398024A3 (fr) * | 1995-06-07 | 2004-12-15 | Karo Bio Ab | utilisation de composés du type hormones thyroidiennes |
WO1996040048A2 (fr) * | 1995-06-07 | 1996-12-19 | Karo Bio Ab | Utilisations innovantes d'hormones thyroidiennes ou de composes ressemblant a des hormones thyroidiennes |
WO1996040048A3 (fr) * | 1995-06-07 | 1997-11-13 | Karobio Ab | Utilisations innovantes d'hormones thyroidiennes ou de composes ressemblant a des hormones thyroidiennes |
US6380255B1 (en) | 1995-06-07 | 2002-04-30 | Karo Bio Ab | Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
US6936244B2 (en) | 1997-10-31 | 2005-08-30 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract |
US6733749B2 (en) | 1997-10-31 | 2004-05-11 | New Horizons Diagnostics Corporation | Throat lozenges for the treatment of Hemosphilus influenza |
US6737079B2 (en) | 1997-10-31 | 2004-05-18 | New Horizons Diagnostics Corporation | Bandage composition containing a phage associated lytic enzyme |
US7687069B2 (en) | 1997-10-31 | 2010-03-30 | Vincent Fischetti | Time release patch containing phage associated lytic enzymes for treating bacterial infections of the skin |
US7232576B2 (en) | 1997-10-31 | 2007-06-19 | New Horizons Diagnostics Corp | Throat lozenge for the treatment of Streptococcus Group A |
US7169408B2 (en) | 1997-10-31 | 2007-01-30 | New Horizons Diagnostics Corp. | Bandage composition containing phage associated lytic enzymes useful for treating dermatological infections |
US6685937B2 (en) | 1997-10-31 | 2004-02-03 | New Horizons Diagnostics Corp. | Chewing gum containing phage associated lytic enzymes for treating streptococcal A infections |
US6875431B2 (en) | 1997-10-31 | 2005-04-05 | New Horizons Diagnostics Corp. | Method for the treatment of bacterial eye infections |
US6881403B2 (en) | 1997-10-31 | 2005-04-19 | New Horizons Diagnostic, Corp | Tampon for the treatment of Streptococcus Group B infections of the vagina |
US6893635B2 (en) | 1997-10-31 | 2005-05-17 | New Horizons Diagnostics Corp | Therapeutic treatment of upper respiratory infections using a nasal spray |
US6899874B2 (en) | 1997-10-31 | 2005-05-31 | New Horizons Diagnostics Corporation | Method for the treatment of bacterial vaginal infections |
US7141241B2 (en) | 1997-10-31 | 2006-11-28 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymes for treating upper respiratory illnesses |
US7014850B2 (en) | 1997-10-31 | 2006-03-21 | New Horizons Diagnostics Corp | Nasal spray for treating streptococcal infections |
US7063837B2 (en) | 1999-09-14 | 2006-06-20 | New Horizons Diagnostics Corp | Syrup composition containing phage associated lytic enzymes |
WO2001019391A1 (fr) * | 1999-09-14 | 2001-03-22 | New Horizons Diagnostics, Inc. | Traitement topique d'infections streptococciques |
US6752988B1 (en) | 2000-04-28 | 2004-06-22 | New Horizons Diagnostic Corp | Method of treating upper resiratory illnesses |
FR2850024A1 (fr) * | 2003-01-16 | 2004-07-23 | Oreal | Compositions pour applicaton topique comprenant au moins un polypeptide de la famille des hydrolases a activite amidasique et/ou un produit capable de moduler son activite. |
EP1438968A1 (fr) * | 2003-01-16 | 2004-07-21 | L'oreal | Compositions pour application topique comprenant au moins un polypeptide de la famille des hydrolases à activité amidasique et/ou un produit capable de moduler son activité |
Also Published As
Publication number | Publication date |
---|---|
FR2357246B1 (fr) | 1978-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2357246A1 (fr) | Nouvelles compositions therapeutiques douees d'activite anti-inflammatoire, antalgique et anti-cellulitique | |
CA973285A (en) | Closed-loop ozone generating and contacting system | |
AU5428486A (en) | Phenyl carbamates | |
AU1596276A (en) | Threaded fastener with cruciform-type recess in head | |
AU8297387A (en) | Anti-inflammatory and analgesic tape for external use | |
FI911207A (fi) | Menetelmä uuden terapeuttisesti käyttökelpoisen retinoidin valmistamiseksi | |
AU4488672A (en) | 2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts | |
JPS542340A (en) | Antiinflammatory composition containing salycilic acid | |
ES8403884A1 (es) | Un procedimiento para la preparacion de nuevos 2,3-diaril-5-halotiofenos. | |
EP0352826A3 (fr) | Utilisation de l'acide 5-aminosalicylique pour le traitement des maladies de la peau | |
CA966865A (en) | Free running portable track | |
NO873427D0 (no) | Hudpleiepreparater med keratolytisk og antiinflammatorisk virkning. | |
IE830664L (en) | Treating acne | |
AU576287B2 (en) | Final cooling of steel strip with jets in tank | |
AU645092B2 (en) | Anti-actinic agent | |
CA987831A (en) | Polyurethane millable gums based on polyesters having unsaturation in both the acid and alcohol portions | |
ES8800048A1 (es) | Mejoras introducidas en un procedimiento para la preparacion de piroxicam o una sal farmaceuticamente aceptable del mismo en forma de composicion anti-inflamatoria mejorada. | |
FR2448903A1 (fr) | Medicament nouveau a base d'agents antimicrobiens, d'enzymes, d'anti-inflammatoires, d'anesthesique local, d'agents keratolytiques, d'agents mucolytiques et d'au moins un emulsionnant | |
CA932746A (en) | METHODS FOR THE PREPARATION OF AROMATIC .alpha.-AMINO ACIDS AND INTERMEDIATES THEREFOR | |
DK0690715T3 (da) | Topisk og systemisk applikation af busphiron eller derivater deraf til behandling af pathologiske tilstande associeret med immunreaktioner | |
FR2358145A1 (fr) | Nouveau medicament anti-inflammatoire, analgesique et antipyretique a base de (p-chlorobenzoyl-1 methyl-2 methoxy-5)-indole-3 acetate de p-acetamidophenol | |
DE3671371D1 (de) | Kombinationspraeparat. | |
AU2540771A (en) | Portable running rail | |
ES404928A1 (es) | Procedimiento para la obtencion de derivados del acido an- tranilico. | |
UA7730A1 (uk) | Засіб одержання складного етілового ефіра аповінкамінової кислоти |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |